{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:33:23Z","timestamp":1768480403309,"version":"3.49.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,30]]},"DOI":"10.1097\/qad.0b013e3282f3cc35","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T06:18:31Z","timestamp":1236233911000},"page":"367-376","source":"Crossref","is-referenced-by-count":38,"title":["Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA"],"prefix":"10.1097","volume":"22","author":[{"given":"Wendy P","family":"Bannister","sequence":"first","affiliation":[]},{"given":"Lidia","family":"Ruiz","sequence":"additional","affiliation":[]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[]},{"given":"Amanda","family":"Mocroft","sequence":"additional","affiliation":[]},{"given":"Ole","family":"Kirk","sequence":"additional","affiliation":[]},{"given":"Schlomo","family":"Staszewski","sequence":"additional","affiliation":[]},{"given":"Clive","family":"Loveday","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Karlsson","sequence":"additional","affiliation":[]},{"given":"Antonella d'Arminio","family":"Monforte","sequence":"additional","affiliation":[]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[]},{"given":"Jens D","family":"Lundgren","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection. 2006 recommendations of the International AIDS Society-USA panel","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMoa031772","article-title":"Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection","volume":"350","author":"Gulick","year":"2004","journal-title":"N Engl J Med"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa030265","article-title":"Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection","volume":"349","author":"Shafer","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJM199912163412501","article-title":"Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults","volume":"341","author":"Staszewski","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/00002030-200112070-00006","article-title":"Viral load outcome of nonnucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients","volume":"15","author":"Phillips","year":"2001","journal-title":"AIDS"},{"key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002030-200201040-00008","article-title":"Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study","volume":"16","author":"Matthews","year":"2002","journal-title":"AIDS"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/339821","article-title":"Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) Study","volume":"185","author":"Cozzi-Lepri","year":"2002","journal-title":"J Infect Dis"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1310\/M47B-R51C-X0MC-K3GW","article-title":"Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naive patients: a cohort study","volume":"3","author":"Keiser","year":"2002","journal-title":"HIV Clin Trials"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1097\/QAD.0b013e3281532b31","article-title":"Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies","volume":"21","author":"Braithwaite","year":"2007","journal-title":"AIDS"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","article-title":"Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study","volume":"363","author":"Van Leth","year":"2004","journal-title":"Lancet"},{"key":"R14-6-20210130","first-page":"670","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"271","author":"Coffin","year":"1995","journal-title":"Science"},{"key":"R15-6-20210130","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.279.24.2000","article-title":"Drug-resistant HIV-1: the virus strikes back","volume":"279","author":"Mayers","year":"1998","journal-title":"JAMA"},{"key":"R16-6-20210130","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/01.aids.0000131310.52526.c7","article-title":"The prevalence of antiretroviral drug resistance in the United States","volume":"18","author":"Richman","year":"2004","journal-title":"AIDS"},{"key":"R17-6-20210130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1742-1241.2006.01146.x","article-title":"Nonnucleoside reverse transcriptase inhibitors: a review","volume":"61","author":"Waters","year":"2007","journal-title":"Int J Clin Pract"},{"key":"R20-6-20210130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1071\/SH03012","article-title":"Virological significance, prevalence and genetic basis of hypersusceptibility to nonnucleoside reverse transcriptase inhibitors","volume":"1","author":"Tachedjian","year":"2004","journal-title":"Sex Health"},{"key":"R22-6-20210130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"R23-6-20210130","first-page":"125","article-title":"Update of the drug resistance mutations in HIV-1: Fall 2006","volume":"14","author":"Johnson","year":"2006","journal-title":"Top HIV Med"},{"key":"R25-6-20210130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/jcla.10022","article-title":"Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy","volume":"16","author":"Quiros-Roldan","year":"2002","journal-title":"J Clin Lab Anal"},{"key":"R26-6-20210130","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1128\/AAC.44.9.2475-2484.2000","article-title":"Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy","volume":"44","author":"Bacheler","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-6-20210130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jmv.2055","article-title":"Resistance profile and cross-resistance of HIV-1 among patients failing a nonnucleoside reverse transcriptase inhibitor-containing regimen","volume":"65","author":"Delaugerre","year":"2001","journal-title":"J Med Virol"},{"key":"R28-6-20210130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/08892220260139503","article-title":"Extent and importance of cross-resistance to efavirenz after nevirapine failure","volume":"18","author":"Casado","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R29-6-20210130","first-page":"S34","article-title":"Impact of Baseline NNRTI Mutations on the Virological Response to TMC125 in the Phase III Clinical Trials DUET-1 and DUET-2","volume":"12","author":"Vingerhoets","year":"2007","journal-title":"Antivir Ther"},{"key":"R30-6-20210130","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1128\/AAC.42.12.3123","article-title":"Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride","volume":"42","author":"Miller","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"R31-6-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/47.4.371","article-title":"Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies","volume":"47","author":"Sabin","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"R32-6-20210130","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","article-title":"Sociodemographic and psychological variables influencing adherence to antiretroviral therapy","volume":"13","author":"Gordillo","year":"1999","journal-title":"AIDS"},{"key":"R33-6-20210130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/135965350200700205","article-title":"Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction\/maintenance randomized trial","volume":"7","author":"Flandre","year":"2002","journal-title":"Antivir Ther"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200801300-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:01:16Z","timestamp":1710126076000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200801300-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282f3cc35","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,30]]}}}